BioCentury | Aug 11, 2016
Financial News

Metabolon raises $15M in series E

...plans for repurchasing shares. Metabolon's prior investors include Camden Partners, Sumitomo Corp. Group (Tokyo:8053) , Aurora Funds...
BioCentury | Nov 3, 2015
Company News

BMS acquires Cardioxyl

...in a series B round from OrbiMed Advisors, Osage University Partners, New Enterprise Associates and Aurora Funds...
BioCentury | Jan 6, 2014
Financial News

Metabolon completes venture financing

...Supply/Service, Diagnostic Date completed: 1/3/14 Type: Venture financing Raised: $15 million Investors: Camden Partners; Sumitomo; Aurora Funds...
BioCentury | Jan 4, 2014
Financial News

Metabolon raises $15 million in E round

...new investor Camden Partners. New investor Sumitomo Corp. (Tokyo:8053) also participated, along with existing investors Aurora Funds...
BioCentury | Sep 9, 2013
Finance

E round in the hand vs. IPO in the bush

...Capital; Lumira Capital; Intersouth Partners; Caisse de depot et placement du Quebec; Morningside Group; and Aurora Funds...
BioCentury | Sep 2, 2013
Financial News

Argos completes venture financing

...TVM Capital; Lumira Capital; Intersouth Partners; Caisse de Depot et Placement du Quebec; Morningside Group; Aurora Funds WIR...
BioCentury | Aug 27, 2013
Financial News

Argos raises $42.5M in series E

...Capital; Lumira Capital; Intersouth Partners; Caisse de depot et placement du Quebec; Morningside Group; and Aurora Funds...
BioCentury | Dec 24, 2012
Financial News

Regado Biosciences completes venture financing

...$51 million Investors: Rusnano; Baxter Ventures; Edmond de Rothschild Investment Partners; Domain Associates; Quaker Partners; Aurora Funds...
BioCentury | Dec 20, 2012
Financial News

Regado raises $51 million in E round

...Rusnano. New investor Baxter Ventures joined existing investors Edmond de Rothschild; Domain Associates; Quaker Partners; Aurora Funds...
BioCentury | Nov 12, 2012
Financial News

Cardioxyl completes venture financing

...11/5/12 Type: Venture financing Raised: $28.1 million Investors: OrbiMed Advisors; Osage Partners; New Enterprise Associates; Aurora Funds WIR...
Items per page:
1 - 10 of 45
BioCentury | Aug 11, 2016
Financial News

Metabolon raises $15M in series E

...plans for repurchasing shares. Metabolon's prior investors include Camden Partners, Sumitomo Corp. Group (Tokyo:8053) , Aurora Funds...
BioCentury | Nov 3, 2015
Company News

BMS acquires Cardioxyl

...in a series B round from OrbiMed Advisors, Osage University Partners, New Enterprise Associates and Aurora Funds...
BioCentury | Jan 6, 2014
Financial News

Metabolon completes venture financing

...Supply/Service, Diagnostic Date completed: 1/3/14 Type: Venture financing Raised: $15 million Investors: Camden Partners; Sumitomo; Aurora Funds...
BioCentury | Jan 4, 2014
Financial News

Metabolon raises $15 million in E round

...new investor Camden Partners. New investor Sumitomo Corp. (Tokyo:8053) also participated, along with existing investors Aurora Funds...
BioCentury | Sep 9, 2013
Finance

E round in the hand vs. IPO in the bush

...Capital; Lumira Capital; Intersouth Partners; Caisse de depot et placement du Quebec; Morningside Group; and Aurora Funds...
BioCentury | Sep 2, 2013
Financial News

Argos completes venture financing

...TVM Capital; Lumira Capital; Intersouth Partners; Caisse de Depot et Placement du Quebec; Morningside Group; Aurora Funds WIR...
BioCentury | Aug 27, 2013
Financial News

Argos raises $42.5M in series E

...Capital; Lumira Capital; Intersouth Partners; Caisse de depot et placement du Quebec; Morningside Group; and Aurora Funds...
BioCentury | Dec 24, 2012
Financial News

Regado Biosciences completes venture financing

...$51 million Investors: Rusnano; Baxter Ventures; Edmond de Rothschild Investment Partners; Domain Associates; Quaker Partners; Aurora Funds...
BioCentury | Dec 20, 2012
Financial News

Regado raises $51 million in E round

...Rusnano. New investor Baxter Ventures joined existing investors Edmond de Rothschild; Domain Associates; Quaker Partners; Aurora Funds...
BioCentury | Nov 12, 2012
Financial News

Cardioxyl completes venture financing

...11/5/12 Type: Venture financing Raised: $28.1 million Investors: OrbiMed Advisors; Osage Partners; New Enterprise Associates; Aurora Funds WIR...
Items per page:
1 - 10 of 45